'MythBusters' star Adam Savage explores longevity and life hacks: 'There's no magic secret'
Former "MythBusters" star Adam Savage is exploring the science of longevity, asking how lifestyle choices, stress and even sleep affect how long we live.
Savage, now a YouTube creator and head of the channel Tested, has partnered with health technology company Medtronic to engage in discussions about longevity. While not a researcher himself, he has taken a deep dive into scientific insights from experts and reflected on his own experiences.
"Longevity has always been a fascination for me," Savage told Fox News Digital in an exclusive interview. "I mean, who doesn't want to know how to live better and maybe even longer? But the real question is what actually works?"
Humanoid Robot Stuns With Perfect Side-flip Acrobatics
He credits his "MythBusters" experience with fueling his passion for scientific exploration.
"Making that show legitimized the practice of science and engineering to me," Savage said. "It made me realize how much of our world can be tested, questioned and improved through experimentation."
Read On The Fox News App
Through his discussions with people on the street for Medtronic, Savage has uncovered key lifestyle factors affecting longevity. He noted a cultural shift in what we consider to be old age, highlighting that people today consider themselves "young-ish" for longer.
Savage also pointed to Blue Zones, regions known for long life expectancy, but questioned whether longevity there stems simply from location or cultural practices.
"We assume people in these areas live longer because of where they are, but what if it's really just the way they live? That's the part that fascinates me," he said. Ai Enables Paralyzed Man To Control Robotic Arm With Brain Signals
"There's no magic secret. It's a mix of daily habits — what you eat, how you move, how you interact with your community, how you handle stress. All those things matter."
Savage has taken a personal interest in testing different longevity strategies in his own life. He spoke candidly with Fox News Digital about his journey with intermittent fasting, which helped him lose 25 pounds and eliminate sleep apnea.
"It's crazy how much of a difference it made," he said. "I didn't just lose weight. I felt sharper, I slept better and I stopped snoring. It was like flipping a switch on my health."
He also reflected on his past smoking habits and what it took to quit.
"I had to admit I wasn't smoking for enjoyment," Savage said. "I was just doing it out of habit. Once I realized that, it was easy to quit."
On alcohol, Savage dismissed the idea of a universal approach, arguing that studies conflict. While he personally cut back, he emphasized that people shouldn't feel guilty about their lifestyle choices.
"I'm a big believer in not feeling guilty about the things that you do to the core, whether it's smoking, whether it's watching something dumb or puzzling for 100 hours at a time," he said. "I don't care about any of those. We all do these things to sort of bring relaxation and down regulate. I just think that alcohol is an especially poor down regulator in the final analysis."
Beyond lifestyle choices, medical advancements are playing an increasingly critical role in extending both lifespan and "healthspan," the years we live without serious disease. Medtronic, which focuses on healthcare technology globally, has developed medical devices designed to manage chronic conditions, improve heart health and advance minimally invasive surgeries.
According to Medtronic, as people live longer, the focus is shifting toward enhancing not just lifespan but quality of life. The company's latest innovations include artificial intelligence-driven healthcare monitoring, robotic-assisted surgeries and advanced pacemakers, all aimed at improving long-term health outcomes. Savage also spoke about the psychological aspects of aging, emphasizing that mindset and community play a significant role in longevity.
"That's really what science foreshadowing is," added Savage. "It's about asking these questions and seeing, 'OK, what numbers are unrealistic.' I think 40 years ago, 150 would have seemed radically unrealistic. Today it seems more realistic, and I think it's entirely reasonable that, let's say, by 2040, we may all have a different cultural answer to that question."Original article source: 'MythBusters' star Adam Savage explores longevity and life hacks: 'There's no magic secret'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Psychedelics as potential mental health treatment are explored by Trump administration
The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared. "The Department shares the goal of ensuring that all Americans — especially our nation's veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression," a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital. "Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges." Fda Approves First Ai Tool To Predict Breast Cancer Risk In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin ("magic mushrooms") to treat mental health disorders. MDMA is not approved for clinical use by the U.S. Food and Drug Administration (FDA), but can be studied in clinical settings. Read On The Fox News App Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means it has "a high potential for abuse, [is not] currently accepted for medical use in treatment in the United States, and [has] a lack of accepted safety for use under medical supervision." Psilocybin-assisted therapy, however, is legal in Oregon, Colorado and New Mexico. Psychedelic medicines are "showing real promise," according to Dr. Luke Twelves, general practitioner and vice president of medical for Lindus Health in London. Clinical trials have found such treatments safe and effective for patients battling serious mental health issues, according to Twelves. Common Supplements And Medications Could Cause Liver Damage, Studies Show "Take psilocybin, for example — it's demonstrating remarkable results for severe depression that hasn't responded to other medications," he told Fox News Digital. "MDMA is showing similar breakthroughs for PTSD treatment." Clinical trials are also investigating how psychedelics could help with end-of-life anxiety, addiction, eating disorders, chronic pain and OCD, he added. Researchers have faced challenges in terms of regulatory hurdles and proper placebo controls, Twelves said. "Given that these treatments could transform [the] lives of people suffering from conditions where nothing else has worked effectively, it's crucial that we complete this research properly," he said. "The goal is to bring safe, proven psychedelic therapies to the patients who need them most." At President Trump's May 1 cabinet meeting, Department of Veterans Affairs Secretary Doug Collins said that "we're opening up the possibility of psychedelic treatment." Retired Army Sergeant Jonathan Lubecki recently told Fox News' Alexandria Hoff that MDMA stopped his PTSD while he was participating in a clinical trial. "[I] took my first dose of MDMA. I've only taken it three times as part of the clinical trial, haven't taken it since, and haven't found the need to take it since, because I haven't had PTSD," he said. Peter Kasperowicz, Department of Veterans Affairs press secretary, told Fox News Digital the department is safely exploring all avenues that promote the health of veterans. Fallujah Vet Turns Medal Of Heroism Into A Healing Mission For Fellow Warriors With Service Dogs Program "Preliminary findings have produced positive results on psychedelic-assisted therapies for treating mental health conditions," he said. The VA is currently running 11 clinical trials in various phases, with a total of some 800 veterans expected to participate. "The goal of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, treatment-resistant depressive disorder, major depressive disorder and potentially other mental health conditions," said Kasperowicz. An MDMA study published in the Jan. 2025 issue of The American Journal of Psychiatry found that the substance is "unlike classical psychedelics." The study noted, "MDMA allows the individual to maintain intact ego functioning and a greater degree of cognitive and perceptual lucidity while still experiencing a prosocial altered state of consciousness that facilitates deeply emotional therapeutic breakthroughs." Click Here To Sign Up For Our Health Newsletter The researchers concluded that MDMA showed "enhanced levels of trust, empathy, self-compassion and a 'window of tolerance'" that traditional psychotherapy lacks. Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin, told Fox News Digital that "the time is now to address the mental health crisis." He said it is "gratifying" that administration officials value the potential benefits of looking into alternative mental health treatments. Cybin is currently in phase 3 of a study of CYB003, a type of psilocybin that has been granted breakthrough therapy designation by the FDA as an additional treatment for major depressive disorder (MDD). "In Cybin's completed Phase 2 MDD study, long-term efficacy results showed that 71% of participants were in remission from depression, and 100% of participants responded to treatment at 12 months after just two 16 mg doses of CYB003," said Drysdale. Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News' senior medical analyst, previously interviewed two of the country's top researchers on psychedelics — Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone. "They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses," Siegel told Fox News Digital at the time. "Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts," Siegel added. Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, emphasized it's important to administer psychedelics in a safe setting when treating mental health conditions. For more Health articles, visit "Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia," Moss previously told Fox News Digital. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials." To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions. Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed article source: Psychedelics as potential mental health treatment are explored by Trump administration
Yahoo
3 days ago
- Yahoo
Common menopause medication might prevent breast cancer while treating hot flashes
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly reduced" breast tissue cell growth, which is a major indicator of cancer progression. A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. Prostate Cancer Drug Now Available To More Patients With Aggressive Form Of Disease This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Read On The Fox News App Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. "The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo," Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. Experimental Women's Cancer Drug Boosts Survival Rates In Notable Study Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. "This would be expected, as the drug is FDA-approved to treat hot flashes." Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The findings are preliminary and have not yet been published in a medical journal. "What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer," said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced "high-risk lesions" — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. "These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options," the release stated. The researchers said they are "encouraged" by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. "Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure," Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. "While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk," she told Fox News Digital. Click Here To Sign Up For Our Health Newsletter Kabraji also noted that the study focused on reducing levels of one specific protein, "which does not always predict reduced recurrence of breast cancer." "This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer," she noted. "Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention." For more Health articles, visit Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. "Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms," she article source: Common menopause medication might prevent breast cancer while treating hot flashes
Tom's Guide
3 days ago
- Tom's Guide
I'm a personal trainer — this physiotherapist's 5 back exercises for ages 55+ are a game-changer for flexibility and pain relief
Back-strengthening exercises are crucial for improving posture, building spine and shoulder stability and reducing the likelihood of developing posture-related injuries. A strong back can even improve exercise performance, reduce hunching and help you avoid muscle weaknesses related to inactivity. The best way to target your back muscles is by using a series of pull exercises combined with mobility. Thanks to a physiotherapist, you can now try five of the best back exercises for ages 55+ to help you build flexibility and improve pain relief. Here they are. Before we dive into the exercises themselves, I want to introduce you to Shrey Vazir, whose easy-to-follow YouTube channel has become a small obsession of mine recently, especially as I regularly train my dad, who is in his 70s. Vazir focuses on an important age category — the over 50s — which is roughly the age at which sarcopenia (muscle mass loss) begins to accelerate. As a result, this is also around the time to be making a strength and resistance program a regular and consistent addition to your daily routine to avoid muscle and bone density loss and prevent pain and injury. Vazir is considered an advanced physiotherapist specializing in low back pain, and his five favorite and simple back pain exercises highlight two key areas: strengthening the muscles of the core, hips, legs and surrounding the spine, plus beginner-friendly stretches to improve flexibility. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. It's worth mentioning that while stretching for flexibility offers short-term improvements, you may find you're back to square one the next day. True flexibility from stretching alone is a bit of a unicorn — long-term change comes from a smart and efficient combination of targeted stretches, mobility exercises and strengthening. With a mass of misinformation available on social media, it's important to find someone you can trust when deciding on the best exercise routine for you. I'm a firm believer that you should be lifting weights (even if it's your bodyweight only) and keep moving well into your later years. In short, don't let someone tell you that hitting a certain age means you need to switch up your routine entirely. Yes, we do have to work against the natural changes in hormones, metabolism and body composition as we age. But I know plenty of people over 50 who are stronger and fitter than they were in their 20s. According to this video, the exercises are gentle and are recommended by Vazir at his clinic in Toronto, Canada. You can modify them if they are too easy or too difficult. Watch the video below for his demonstrations, guidelines and suggestions for scaling, plus sets and reps. This is considered an 'easy' stretching exercise you can perform on your back. Simply take your knee or knees up to your chest and hold behind your leg or legs to draw them closer. Focus on keeping your lower back supported throughout. Vazir recommends 5 sets per leg and hold for 10 seconds each time. Also considered a beginner-friendly move, you'll just need a chair or bench to sit on. From here, Vazir guides you to slightly open your legs and place your feet apart, then place your hands on your thighs or between your legs and slowly slide them downward as you bend forward to stretch out your lower back. Try 10 reps with a 5-second hold each time. The first strengthening exercise on Vasir's list is the crunch, which has been modified for a beginner-friendly version. Seated on a bench or chair, Vazir asks you to cross your arms over your chest, squeeze your stomach, then drive your chest forward toward your thighs. We offer some crunch variations here if this exercise feels too easy. Repeat for 2 sets of 10 reps. On your back, tighten your stomach and draw your belly button toward your spine (activation), then hold that tension and lift your knee into the air, lower it and repeat on the other side. Aim for 2 to 3 sets of 10 reps (5 per leg) or lift both legs together if you prefer. We love a dead bug exercise, and so does Vazir. Lay on the floor — legs lifted to 90 degrees and arms extended above your chest. One at a time, you'll extend one arm and the opposite leg, then return to center and switch sides. If you prefer, you could just hold the dead bug position without moving your arms and legs. You could also try just arms, just legs, or even one arm and one leg (in a hold) at a time — Vazir demonstrates your options. Hold for 10 to 30 seconds and repeat 3 sets.
